Globally Experienced Strategic Consultant, Flavia D'Alo, joins the Nutrition Innovation Board
Nutrition Innovation is pleased to announce that highly experienced, global strategic consultant, Flavia D'Alo has joined the Nutrition Innovation Board to help guide future growth and expansion of the company.
"Flavia has had a strong track record of over 30 years in helping companies and organisations understand and achieve their full potential." said Dr David Kannar, Chairman and Founder of Nutrition Innovation. "She has worked across industries and jurisdictions, gaining insight on what works best and the tools and approaches that promote success. Her background and experience inside world-class companies like Deloitte, BHP, Qantas, Guidant (Medical devices) and Johnson and Johnson, has proven invaluable to other companies and Boards in areas such as process redesign, people strategy, business leadership, operational leadership and enterprise technology. We welcome her to the team."
"I'm excited to be part of the Nutrition Innovation Board and help contribute to the company's mission of helping individuals lead healthier lives through innovation and change," said Flavia D'Alo. "I've been impressed by the incredible strides that the Founders of Nutrition Innovation have achieved and believe in the potential to positively impact world health. I am a passionate believer in creating progressive and nurturing environments where everyone is able to thrive and I look forward to contributing at a strategic level to the success of the company and the benefit to millions of individuals."
As part of this development, Director of Finance for Nutrition Innovation and Seed Investor, Caroline Poon, will take a step back from the Board but will remain fully engaged on an operational level and continue to lead all of the important financial operations of the company. "On behalf of the Founders, Management and Investors, I would like to sincerely thank Caroline for the passion, dedication and expertise she has given to Nutrition Innovation as a Director of the company and I look forward to continued collaboration with her." said Dr Kannar.